Investment Q&A

Q: Hi, I received shares in this company (HLS) via a reverse takeover of ADM (Automodular) back in late '17.
I don't see any other questions on this company thus the inquiry. What is your valued opinion of HLS?
From their web page...'HLS Therapeutics is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. '
They seem to have a couple of drugs Vascepa, Clozaril and Absorica that are or will generate decent revenues going forward.
They also introduced a quarterly dividend recently and I know you favour companies when this occurs.
Are they a 'show me' story right now and patience is required for a couple quarters to see how they proceed, ie it looks like they will be filing for approval with Health Canada in early 2019 for Vascepa (it's already FDA approved).
Analysts targets are for around $20 for 2019 (from your 'Companies' page).

Cheers,
Steve

Q: Hi, Could you tell me if XTR and MFT would compliment each other, or is there some or too much overlap between the two, or in other words is there much correlation, thanks?

Q: Is there any stock(s) out there US or CDN that showed up on your radar screen lately that you think has a good momentum but also it is not stratospheric levels? I have some money that i need to deploy but don't want to add to my current holdings.

Q: BNS missed estimates while BMO beat,thanks to US earnings.Your comments please.

Q: Hi 5i team,
I'm thinking of buying VGRO Vanguard Growth. I like the fact that it is one balanced ETF for global diversification and rebalancing by itself. However, I've read comments that the funds are not optimized for tax efficiency. What does this mean? Is it appropriate to be held inside TFSA? Any better ETFs suggestions? Thanks.

Q: hgm etf was a top pick on bnn! what do you think of this etf?

Q: Hello 5i,
Could I have you thoughts on the growth prospects of LivePerson(LPSN)?
The technology sounds like it has amazing potential or is it hype? Any competition?
Thanks
Dave

Q: Hi All at 5i! I hold GUD, but was wondering if I should swap it out for MU. I am looking for growth. What would you suggest? Cheers, Tamara

Q: Hi, Could you please post the upcoming quarterly earning estimates for these companies. Thanks

Q: Goodmorning
What are your thoughts on this company for a long term hold?
Thks
Marcel

Q: Could you please summarise the dividend policy for this pref.
I am thinking if buying it for income - is it a "trap"?
Is there a better pref at 6% +/- yield?
Thanks

Q: Hi

I currently own GILD. Should I sell it and switch to BIIB or any other biotech. What are your thoughts about medical distribution companies (ABC, CAH, MCK) Which one would you recommend and any threat from Amazon. Should healthcare plans companies be part of healthcare portfolio and which one do you recommend.

Great service
Thanks
Ninad

Q: I've done very well with SHOP (thanks to 5i) but it has grown to 12% of my overall portfolio. I really like to let the winners run, and am quite risk tolerant, however I am considering selling 20% and reinvesting the proceeds. I plan to top up KXS, which seems has good momentum, but need some other suggestions. What other technology stocks would you suggest at this time? Options outside of tech would be appreciated too.

Q: 1:03 PM 2/24/2019
I am increasingly concerned about the financial stability and credit quality of several of my investments.
Could you please provide the S&P or DBRS issuer rating or bond rating of : ENB, TRP, PKI, BCE, CSW.A, AW.UN, SIA.
This information is very difficult for me to find and is often quite dated. Could you suggest a source I could use.
Thank you........... Paul K

Q: Hi,
Can I have your opinion on Metlife. I have held it for a while but it hasn't moved. However, it pays a nice dividend. Worth holding on?

Thanks

Q: I would like your opinion on Enova International (ENVA). I have had good success with GoEasy and this seems to be a similar type company with operations in the US, UK and Brazil. Any comments/ thoughts would be appreciated. Thanks in advance.

Q: I looked at insider trading on Canadian Insider web site. Between Oct 18-Jan 21st 2019, insider buying is huge. I see directors buying 1.6 million shares. Others, Joseph Crumb 3.4 M. Chiabra Tommasso also director 2.0 M.
Roy Sebag CEO 6 trades for 525 thousand shares. Also for XAU , he purchased in 5 trades 863 thousand shares. I do not normally check insider trading activity, but this seems out of the ordinary. Please verify my numbers. If exact, have you seen such large insider buying before ?
If so, would you recommend taking a position in Mene.
thanks for your help.

Q: Just a comment for some additional perspective on the automatic share transaction plan of CSU's CEO: If today's share price action was a result of the announcement that the CEO may be selling up to 100 shares per week for a year (up to 5,200 shares), then the sellers who were bailing out are just being nutty. At the rate of 100 shares per week, it would take him approximately 84 years to divest himself of his current CSU shares position. Now there's an investment horizon for you!

Q: Pollard Banknote last reported earning Nov6 . Do you know when they report their 4th Q results
Thank You
KM

Q: Hello, I would like to know how you determine the valuation of a company. It seems every industry is assigned different pe ratios. How is that established? Once a company reaches a valuation does that mean it is time to sell?